Related Experiment Video
Updated: Sep 5, 2025
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.5K
Digital tools in allergy and respiratory care
Elisabeth Verhoeven1, Philip Rouadi2, Eliane Abou Jaoude3
1Department of Otorhinolaryngology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
The World Allergy Organization Journal
|July 5, 2022
Summary
Digital health tools enhance allergy and respiratory care, but standardization is needed. The World Allergy Organization (WAO) proposes criteria for e-health tool quality, patient appeal, and clinical applicability.
Area of Science:
- Digital health
- Allergy and respiratory medicine
- E-health
Background:
- Patient care in allergy and respiratory fields is rapidly evolving with digital tools.
- The COVID-19 pandemic accelerated the adoption of e-health solutions due to impaired healthcare access.
- Numerous e-health tools have emerged globally, varying in features and benefits.
Purpose of the Study:
- To define and propose criteria for the quality, appeal, and applicability of e-health tools in allergy and respiratory care.
- To address the need for standardization in e-health tool development and implementation.
- To improve patient health outcomes through better e-health integration.
Main Methods:
- The Upper Airway Diseases Committee of the World Allergy Organization (WAO) initiative.
- Defining criteria from patient, clinician, and academic perspectives.
- Considering legal and device-related factors for e-health tool acceptance and effectiveness.
Main Results:
- Identified key features important for the acceptance, effectiveness, and long-term use of e-health tools.
- Highlighted differing needs and expectations between patients and healthcare providers regarding digital tools.
- Emphasized the necessity for quality assurance criteria and standardization.
Conclusions:
- Standardization and defined quality criteria are crucial for effective e-health tool integration in allergy and respiratory care.
- A multi-perspective approach (patient, clinician, academic) is essential for developing suitable e-health tools.
- The WAO initiative aims to enhance patient health outcomes by guiding the development and use of e-health technologies.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
569
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
569
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:23Inhaled Medications
380
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
380
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
380
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
380
01:20Asthma: Pathogenesis and Management
560
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
560
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
431
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
431